NDC Package 61786-644-02 Breo Ellipta

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
61786-644-02
Package Description:
30 POWDER in 1 INHALER
Product Code:
Proprietary Name:
Breo Ellipta
Usage Information:
This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.
11-Digit NDC Billing Format:
61786064402
Labeler Name:
Remedyrepack Inc.
Sample Package:
No
FDA Application Number:
NDA204275
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
04-04-2016
End Marketing Date:
04-05-2016
Listing Expiration Date:
04-05-2016
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 61786-644-02?

The NDC Packaged Code 61786-644-02 is assigned to a package of 30 powder in 1 inhaler of Breo Ellipta, labeled by Remedyrepack Inc.. The product's dosage form is and is administered via form.

Is NDC 61786-644 included in the NDC Directory?

No, Breo Ellipta with product code 61786-644 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Remedyrepack Inc. on April 04, 2016 and its listing in the NDC Directory is set to expire on April 05, 2016 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 61786-644-02?

The 11-digit format is 61786064402. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-261786-644-025-4-261786-0644-02